Igf-1-lr3 recalls
The FDA has published 2 recalls involving Igf-1-lr3 since 2019. The latest was reported on 20 Feb 2019. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2019
Last 12 months0reported
Class I00% of total
Ongoing0latest 20 Feb 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why igf-1-lr3 is recalled
Companies
By year
All igf-1-lr3 recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | IGF-1 LR3, 620 mcg injection recalled by Promise Pharmacy | Promise Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | IGF-1-LR3, 3 mg injection recalled by Promise Pharmacy | Promise Pharmacy | Sterility | Nationwide |
Should you stop taking Igf-1-lr3?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.